Clinical Trial Update: Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nimotuzumab plus camrelizumab with neoadjuvant chemotherapy for esophageal squamous cell carcinoma; the study is currently enr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Peking University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: ENROLLING_BY_INVITATION